| 项目编号 |
PRJCA027651 |
| 项目标题 |
Gefitinib plus anlotinib for untreated, EGFR-mutated, advanced NSCLC (FL-ALTER): A multicenter phase III trial |
| 涉及领域 |
Medical |
| 数据类型 |
Whole genome sequencing
Genome sequencing and assembly
Raw sequence reads
Genome sequencing
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
Blood samples for ctDNA analysis were collected from each patient at baseline, first evaluation, and PD. |
| 样品范围 |
Multiisolate |
| 发布日期 |
2024-07-18 |
| 出版信息 |
| PubMed ID |
文章标题 |
杂志名称 |
Doi |
发表年份 |
| 39134529
|
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR- mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial
|
Signal Transduction and Targeted Therapy
|
10.1038/s41392-024-01927-9
|
2024
|
|
|
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| No funding support
|
|
|
|
|
|
| 提交者 |
Li
Zhang (zhangli@sysucc.org.cn)
|
| 提交单位 |
Sun Yat-sen University Cancer Center |
| 提交日期 |
2024-07-02 |
